Research on the Role of Combined Chemotherapy and Radiotherapy in Patients With N+ Non-Metastatic Metaplastic Breast Carcinoma: A Competing Risk Analysis Model Based on the SEER database, 2000 to 2015

PURPOSE: Due to the rarity of metaplastic breast carcinoma (MpBC), no randomized trials have investigated the role of combined chemotherapy and radiotherapy (CCRP) in this condition. We aimed to explore and identify the effectiveness of CCRP in patients with regional lymph node metastasis (N+) non-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yifei, Yang, Zejian, Gao, Yihan, Li, Kunlong, Qiu, Pei, Chen, Heyan, Pu, Shengyu, Wang, Bo, Zhou, Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862760/
https://www.ncbi.nlm.nih.gov/pubmed/33552959
http://dx.doi.org/10.3389/fonc.2020.583488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862760/
https://www.ncbi.nlm.nih.gov/pubmed/33552959
http://dx.doi.org/10.3389/fonc.2020.583488

Ejemplares similares